Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
The successful evaluation of drug treatments and their protocols hinges on the effective gathering and sharing of thorough, timely, and high-quality data. To support this need, the Omda Compos suite of solutions is specifically crafted to enhance the management and effortless exchange of medical information across the clinical landscape. This innovative platform guarantees that users and applications involved in clinical trials and registries have easy access to vital data, fostering improved collaboration and effective data usage. At the heart of the Compos platform lies Omda Compos QR, which features a sophisticated database structure, data warehousing functions, user management, and other critical elements that uphold data integrity throughout the entire process, from collection to analysis. Maintaining streamlined user access and efficient logging practices is crucial for any clinical registry or trial. Within Omda Compos QR, user roles are defined to regulate access to designated sites, thereby enhancing security and control over the data management process. By prioritizing these features, the platform not only supports researchers but also improves the overall quality of clinical data handling.
Description
Omda Cytodose, an oncology medication management solution from Omda, employs clinically validated protocols along with patient-specific parameters to ensure safer and more effective treatments for individuals battling cancer. This innovative system enhances the quality of care provided to oncology patients by fostering a seamless and collaborative treatment process among healthcare professionals, including doctors, pharmacists, and nurses. Omda Cytodose is designed to support a comprehensive range of adult and pediatric cancers, accommodating various medical treatments such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Initially created by a team of clinicians at one of Norway's premier cancer centers and introduced in 2001, Omda Cytodose has gained widespread adoption across healthcare regions in the Nordic countries, leading to the fulfillment of millions of medication orders. With a robust 15-year history marked by stability, reliability, and safety, the system is meticulously configured with chemotherapy protocols that reflect both national and international guidelines. This ensures that patients receive the most up-to-date treatment options available, further enhancing their chances of successful outcomes.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Omda
Founded
1999
Country
Norway
Website
omda.com/solutions/health-analytics/omda-compos/
Vendor Details
Company Name
Omda
Founded
1999
Country
Norway
Website
omda.com/solutions/medication-management/omda-cytodose/